Alison Taylor

1.2k total citations · 1 hit paper
6 papers, 543 citations indexed

About

Alison Taylor is a scholar working on Oncology, Surgery and Infectious Diseases. According to data from OpenAlex, Alison Taylor has authored 6 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 1 paper in Infectious Diseases. Recurrent topics in Alison Taylor's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Alison Taylor is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and SARS-CoV-2 and COVID-19 Research (1 paper). Alison Taylor collaborates with scholars based in United Kingdom, United States and South Africa. Alison Taylor's co-authors include Jorge Luis Galeano Niño, Kaitlyn D. LaCourse, Jeffrey Houlton, Hanrui Wu, Neal D. Futran, Christopher D. Johnston, Brittany Barber, Susan Bullman, Ewa Sicińska and Samuel S. Minot and has published in prestigious journals such as Nature, Cancer Cell and Clinics and Research in Hepatology and Gastroenterology.

In The Last Decade

Alison Taylor

5 papers receiving 539 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer

2022 516 citations Jorge Luis Galeano Niño, Hanrui Wu et al. Nature profile →

Peers

Countries citing papers authored by Alison Taylor

Since Specialization

Citations

This map shows the geographic impact of Alison Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Taylor more than expected).

Fields of papers citing papers by Alison Taylor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Taylor. The network helps show where Alison Taylor may publish in the future.

Co-authorship network of co-authors of Alison Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Taylor. A scholar is included among the top collaborators of Alison Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Taylor. Alison Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy 2025 ·Cancer Cell ·Brian S. Henick, Alison Taylor, Hiroshi Nakagawa, Kwok‐Kin Wong, (unknown), Anil K. Rustgi	2
2	758 Neurodevelopmental traits in young people with liver disease: time for action! 2023 ·(unknown), (unknown), Deepak Joshi, (unknown), Alison Taylor, (unknown), Anil Dhawan, Gráinne McAlonan, Marianne Samyn	0
3	Factors Determining Long Term Anti-Tumor Responses to Immune Checkpoint Blockade Therapy 2023 ·Frontiers research topics ·Alison Taylor, Graham P. Cook, Roberta Zappasodi	1
4	Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer breakdown → 2022 ·Nature ·Jorge Luis Galeano Niño, Hanrui Wu, Kaitlyn D. LaCourse, (unknown), (unknown), Brittany Barber, Neal D. Futran, Jeffrey Houlton, (unknown), Ewa Sicińska, Alison Taylor, Samuel S. Minot, Christopher D. Johnston, Susan Bullman	516
5	Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis 2022 ·Clinics and Research in Hepatology and Gastroenterology ·Jeremy Nayagam, (unknown), Alison Taylor, Michael A. Heneghan, P Dubois, Bu Hayee, (unknown), (unknown), Marianne Samyn, Deepak Joshi, Alexandra Kent	2
6	Specific COVID-19 Symptoms Correlate with High Antibody Levels against SARS-CoV-2 2021 ·ImmunoHorizons ·(unknown), Sarah O’Connell, Tammy Armbrust, (unknown), Sandeep Narpala, Peter Halfmann, (unknown), (unknown), (unknown), Alison Taylor, Britta Flach, David H. O’Connor, Yoshihiro Kawaoka, Adrian B. McDermott, Ajay K. Sethi, Miriam A. Shelef	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact